PURPOSE: To determine the agreement between the Humphrey Matrix perimeter 10-2 test and the 10-2 Humphrey Field Analyzer ( @entity21419 ) test when assessing visual function in @entity1 with @entity1020 ( @entity1020 ). METHODS: Forty-two eyes of 42 subjects with @entity1020 (average 75.0 years, SD=6.2: median visual acuity in logarithm of the minimum angle of resolution of 0.26, range, -0.12 to 1.04) were evaluated with the Matrix and @entity21419 10-2 visual field tests. @entity5494 ( @entity5494 ), pattern standard deviation, and test time were recorded. We calculated spatial concordance of individual test locations, being the proportion of spatially agreeing locations with identical classification (normal vs. abnormal, p < 5%) on the pattern deviation plot. As multiple @entity21419 stimuli overlapped with some Matrix locations, several criteria for grouping @entity21419 data into locations were investigated. RESULTS: Both @entity5494 and pattern standard deviation were significantly correlated for the two devices (r(2)=0.79 and r(2)=0.80, respectively, p<0.0001). Using our standard criterion for abnormal @entity21419 locations (>= 50% stimuli abnormal), the median spatial concordance was 0.76, with 95% of tests giving a concordance of >= 0.59. A small, but significant, increase in concordance occurred when a stricter criterion (all stimuli abnormal at a location) was applied. Median fixation loss percentages were 7 and 0% for the @entity21419 and Matrix, respectively. Visual acuity in logarithm of the minimum angle of resolution showed modest correlations with both @entity154 ( @entity21419 @entity5494 : r(2)=0.39, p<0.0001) and size of defect (number of abnormal points on the @entity21419 : r(2)=0.24, p<0.0001). CONCLUSIONS: Using a simple metric to calculate spatial concordance, the Matrix 10-2 test quantifies the spatial extent of significant @entity227 in @entity1020 in a manner similar to the @entity21419 10-2. The spatial extent and depth of central @entity227 in @entity1020 are only modestly predicted by visual acuity measurements.

Measuring visual function in XXXX with frequency-doubling (matrix) perimetry.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity154 :: ('MESH:D000013', 'Disease') :: ['defect depth'] @entity227 :: ('MESH:D014786', 'Disease') :: ['visual field loss', 'depression of the central visual fields'] @entity5494 :: ('MESH:D010262', 'Disease') :: ['Mean deviation', 'MD'] @entity21419 :: ('CHEBI:30775', 'Chemical') :: ['HFA'] @entity1020 :: ('MESH:D008268', 'Disease') :: ['AMD', 'age-related macular degeneration']
@entity1020 :: (MESH:D008268,Disease) :: ['age-related macular degeneration']
